AdaptHealth (NASDAQ:AHCO) Shares Gap Down Following Weak Earnings

05 May 2026, 11:26 by Amy Steele · The Cerbat Gem

AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report)’s share price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $13.04, but opened at $10.98. AdaptHealth shares last traded at $11.3140, with a volume of 851,195 shares traded.

The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.13). AdaptHealth had a positive return on equity of 3.42% and a negative net margin of 2.18%.The firm had revenue of $819.80 million for the quarter, compared to analysts’ expectations of $796.63 million. During the same quarter in the previous year, the firm posted ($0.05) EPS. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year.

Analyst Ratings Changes

AHCO has been the subject of a number of analyst reports. Leerink Partners decreased their price target on AdaptHealth from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Thursday, February 26th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $11.00 price target on shares of AdaptHealth in a report on Monday, April 20th. Weiss Ratings cut AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a research note on Wednesday, February 25th. Royal Bank Of Canada restated an “outperform” rating and set a $13.00 price objective on shares of AdaptHealth in a research note on Wednesday, February 25th. Finally, Wall Street Zen lowered AdaptHealth from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $13.00.

Get Our Latest Analysis on AHCO

Insider Activity at AdaptHealth

In other AdaptHealth news, major shareholder Richard M. Cashin, Jr. purchased 820,528 shares of the stock in a transaction dated Tuesday, March 10th. The shares were bought at an average cost of $9.73 per share, with a total value of $7,983,737.44. Following the completion of the acquisition, the insider owned 14,638,708 shares of the company’s stock, valued at approximately $142,434,628.84. This trade represents a 5.94% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders acquired 2,494,518 shares of company stock worth $24,352,291 over the last quarter. 1.55% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Rockefeller Capital Management L.P. increased its holdings in shares of AdaptHealth by 433.0% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after purchasing an additional 2,100 shares during the period. FNY Investment Advisers LLC bought a new stake in AdaptHealth during the third quarter worth approximately $35,000. PNC Financial Services Group Inc. raised its holdings in AdaptHealth by 22.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after purchasing an additional 1,279 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in AdaptHealth by 318.0% during the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after purchasing an additional 7,297 shares in the last quarter. Finally, Tidal Investments LLC bought a new stake in AdaptHealth during the second quarter worth approximately $96,000. 82.67% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Stock Performance

The stock has a market cap of $1.54 billion, a P/E ratio of -20.62, a PEG ratio of 1.52 and a beta of 1.57. The company has a fifty day moving average of $11.20 and a 200 day moving average of $10.36. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.02 and a quick ratio of 0.81.

AdaptHealth Company Profile

(Get Free Report)

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.